Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box.

Stefan Biendl Cécile Häberli Jennifer Keiser

Published in: Expert review of anti-infective therapy (2021)

MMV1581558 discovered from screening the PRB represents a novel antischistosomal scaffold with high in vitro antischistosomal activity amenable to chemical modification for drug development.

Keyphrases

tissue engineering
sars cov
coronavirus disease
small molecule
minimally invasive
transcription factor
high throughput
binding protein